BioGend Therapeutics Co., Ltd. (TPEX:6733)
35.85
-0.25 (-0.69%)
Mar 3, 2026, 1:30 PM CST
7.01% (1Y)
| Market Cap | 4.46B +9.9% |
| Revenue (ttm) | 222.34M +32.6% |
| Net Income | -84.61M |
| EPS | -0.69 |
| Shares Out | 124.36M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 329,273 |
| Average Volume | 217,958 |
| Open | 36.10 |
| Previous Close | 36.10 |
| Day's Range | 35.70 - 36.70 |
| 52-Week Range | 23.20 - 49.15 |
| Beta | 0.19 |
| RSI | 39.16 |
| Earnings Date | Feb 26, 2026 |